International Breast Cancer Biomarker,Standard of Care and Real World Outcomes Study

CompletedOBSERVATIONAL
Enrollment

873

Participants

Timeline

Start Date

March 13, 2017

Primary Completion Date

May 20, 2019

Study Completion Date

May 20, 2019

Conditions
Breast Cancer
Interventions
GENETIC

Germline BRCA Test (blood)

If unavailable from the patient medical records, gBRCA gene mutation status will be tested as aligned to local clinical practice using a blood sample obtained preferably during routine clinical practice. (Note: Blood samples may be shipped to a central laboratory for testing and storage, based on local regulations for shipment of blood samples.)

GENETIC

FoundationOne Dx Genomic Profile (archival Tumour Specimen)

"Archival tumour specimen will be requested from all patients in the informed consent, but is not required for study enrolment (optional consent). Where sufficient archival tumour specimen is available and patients have consented to tumour specimen testing, FoundationOne Dx genomic profiling may take place as follows:~* Tumour Specimen: Acceptable samples include formalin-fixed, paraffin embedded (FFPE) tissue (preferred) or FFPE specimens, including core needle biopsies, fine-needle aspirates and effusion cytologies.~* Tumour Testing (optional): archival tumour specimens, where available, will be tested for mutations in HRR genes including BRCA1 and BRCA2 and other genomic alterations using the FoundationOne Dx genomic profile."

OTHER

Follow-up

"Patients who test positive for a gBRCA gene mutation, and/or sBRCA or other HRR gene mutations (optional testing), will be followed prospectively for assessment of treatment patterns and associated clinical outcomes up to 30-months.~\- Patients who test negative for gBRCA gene mutations, sBRCA and other HRR gene mutations, no further data will be collected post baseline. Patients presenting other genomic alterations that are identified by the FoundationOne Dx genomic profile will not continue beyond baseline as part of this study."

Trial Locations (98)

23601

Research Site, Newport News

33012

Research Site, Hialeah

75028

Research Site, Flower Mound

75246

Research Site, Dallas

75460

Research Site, Paris

76210

Research Site, Denton

77024

Research Site, Houston

77089

Research Site, Houston

77380

Research Site, The Woodlands

78217

Research Site, San Antonio

80218

Research Site, Denver

93105

Research Site, Santa Barbara

98684

Research Site, Vancouver

98801

Research Site, Wenatchee

Unknown

Research Site, Redcliffe

Research Site, Kurralta Park

Research Site, Ballarat

Research Site, Dobrich

Research Site, Rousse

Research Site, Sofia

Research Site, Tübingen

Research Site, Budapest

Research Site, Szeged

Research Site, Szekszárd

Research Site, Szolnok

Research Site, Carpi

Research Site, Castellanza

Research Site, Milan

Research Site, Pavia

Research Site, Reggio Emilia

Research Site, Kamogawa-shi

Research Site, Matsuyama

Research Site, Fukuoka

Research Site, Sapporo

Research Site, Sendai

Research Site, Osaka

Research Site, Chūōku

Research Site, Brzozów

Research Site, Opole

Research Site, Warsaw

Research Site, Wałbrzych

Research Site, Wieliszew

Research Site, Wroclaw

Research Site, Żory

Research Site, Chelyabinsk

Research Site, Krasnodar

Research Site, Novosibirsk

Research Site, Omsk

Research Site, Pyatigorsk

Research Site, Ryazan

Research Site, Tomsk

Research Site, Goyang-si

Research Site, Seongnam-si

Research Site, Busan

Research Site, Seoul

Research Site, Ulsan

Research Site, Terrassa

Research Site, A Coruña

Research Site, Alcorcón

Research Site, San Sebastián de los Reyes

Research Site, Barcelona

Research Site, Burgos

Research Site, Girona

Research Site, Huelva

Research Site, Changhua

Research Site, Kaohsiung City

Research Site, Taichung

Research Site, Tainan City

Research Site, Taipei

Research Site, Adana

Research Site, Ankara

Research Site, Antalya

Research Site, Diyarbakır

Research Site, Istanbul

Research Site, Izmir

Research Site, Kocaeli

Research Site, Sakarya

Research Site, Samsun

Research Site, Tekirdağ

Research Site, Trabzon

Research Site, Van

Research Site, Huntingdon

Research Site, Peterborough

Research Site, Truro

Research Site, Derby

Research Site, Exeter

Research Site, Worthing

Research Site, London

Research Site, Blackpool

Research Site, Lancaster

Research Site, Stoke-on-Trent

Research Site, Warwick

Research Site, Wolverhampton

Research Site, Huddersfield

K7L 5P9

Research Site, Kingston

N2G 1G3

Research Site, Kitchener

G7H 5H6

Research Site, Chicoutimi

G1S 4L8

Research Site, Québec

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Quintiles; University of Tubingen - Germany

UNKNOWN

lead

AstraZeneca

INDUSTRY